TCL Archive Three Fourths Of Pediatric Patients are Getting Best Treatment; NCI Goal: Reach all The Others May 20, 1977
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.” October 29, 2004